lobbying_activities: 2867421

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2867421	78a2c646-e6f0-49d2-9ac0-144ff65f7bca	Q3	RICCHETTI INCORPORATED	62778	EISAI, INC.	2022	third_quarter	PHA	Issues related to coverage of Alzheimer's drugs and diagnostics under Federal health care programs; Issues related to drug pricing and access, and Medicare and Medicaid reimbursement; Issues related to pharmaceutical industry, generally	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2022-10-17T11:15:06-04:00